Innoviva share price today

(INVA)

Innoviva share price is $17.4 & ₹1,491.88 as on 3 Jan 2025, 2.30 'hrs' IST

$17.4

▲

0.05

(0.29%)

Market is closed - opens 8 PM, 03 Jan 2025

View live Innoviva share price in Dollar and Rupees. Guide to invest in Innoviva from India. Also see the sentimental analysis on Indian investors investing in Innoviva. Get details on the Indian mutual funds that are investing in Innoviva. Get Analyst recommendations and forecasts along with all the Innoviva's financials.

Innoviva share price movements

Today's Low: $17.29
Today's High: $17.57
$17.40
0.63%
Downside
Day's Volatility :1.59%
Upside
0.97%
52 Weeks Low: $14.33
52 Weeks High: $21.28
$17.40
17.67%
Downside
52 Weeks Volatility :32.68%
Upside
18.23%

Innoviva Returns

Period	Innoviva, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-11.79%	-10.0%	0.0%
6 Months	6.05%	-4.7%	0.0%
1 Year	3.4%	-0.9%	0.0%
3 Years	-0.34%	-2.4%	-21.2%

Innoviva Key Statistics

in dollars & INR

Previous Close	$17.35
Open	$17.47
Today's High	$17.5699
Today's Low	$17.29
Market Capitalization	$1.1B
Today's Volume	$543.0K
52 Week High	$21.28
52 Week Low	$14.325
Revenue TTM	$352.7M
EBITDA	$221.2M
Earnings Per Share (EPS)	$0.8
PE Ratio	21.69
Profit Margin	18.31%
Quarterly Earnings Growth YOY	-0.98%
Return On Equity TTM	9.97%

How to invest in Innoviva from India?

It is very easy for Indian residents to invest directly in Innoviva from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Innoviva stock in both Indian Rupees (INR) and US Dollars (USD). Search for Innoviva or INVA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Innoviva or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Innoviva shares which would translate to 0.049 fractional shares of Innoviva as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Innoviva, in just a few clicks!

Returns in Innoviva for Indian investors in Rupees

Investment Value

₹1,00,000

Innoviva investment value today

Current value as on today

₹1,06,670

Returns

₹6,670

(+6.67%)

Returns from Innoviva Stock

₹3,695 (+3.69%)

Dollar Returns

₹2,975 (+2.97%)

Indian investors sentiment towards Innoviva

109%

Period: Oct 4, 2024 to Jan 2, 2025. Change in 30 Days versus previous period

Search volume for Innoviva on INDmoney from India has grown in the last 30 days as on Jan 3, 2025. 109% more investors are searching Innoviva in the last 30 days versus the previous period.

Global Institutional Holdings in Innoviva

BlackRock Inc
15.38%
Sarissa Capital Management LP
11.62%
Franklin Resources Inc
10.77%
Vanguard Group Inc
9.95%
Dimensional Fund Advisors, Inc.
7.50%
Renaissance Technologies Corp
6.92%

Analyst Recommendation on Innoviva

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Innoviva(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Innoviva

What analysts predicted

Upside of 9.2%

Current:

$17.40

Target:

$19.00

Insights on Innoviva

Price Movement
In the last 1 month, INVA stock has moved down by -9.3%
Decreasing Revenue
Revenue is down for the last 2 quarters, 103.35M → 89.50M (in $), with an average decrease of 13.4% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -34.68M → 1.21M (in $), with an average increase of 2959.4% per quarter
INVA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 20.7% return, outperforming this stock by 14.7%
INVA vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 38.2%
Price to Sales
ForINVA every $1 of sales, investors are willing to pay $3.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Innoviva Technicals Summary

Sell

Neutral

Buy

Innoviva is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Innoviva Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Innoviva, Inc.	-8.06%	6.05%	3.4%	-0.34%	24.46%
Regeneron Pharmaceuticals, Inc.	-4.97%	-31.12%	-21.91%	15.48%	91.62%
Biontech Se	-1.42%	42.28%	6.01%	-49.15%	155.61%
Alnylam Pharmaceuticals, Inc.	-6.56%	-6.26%	22.36%	42.41%	102.91%
Vertex Pharmaceuticals Incorporated	-11.88%	-15.14%	-3.23%	81.51%	79.75%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Innoviva, Inc.	21.69	21.69	0.24	0.43	0.1	0.09	NA	10.68
Regeneron Pharmaceuticals, Inc.	17.61	17.61	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Innoviva, Inc.	Sell	$1.1B	24.46%	21.69	18.31%
Regeneron Pharmaceuticals, Inc.	Buy	$78.3B	91.62%	17.61	33.61%
Biontech Se	Buy	$27.3B	155.61%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	102.91%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$103.7B	79.75%	32.84	-4.51%

About Innoviva

innoviva is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. innoviva's portfolio is anchored by the respiratory assets partnered with glaxo group limited (gsk), including relvar®/breo® ellipta® and anoro® ellipta®, which were jointly developed by innoviva and gsk. under the agreement with gsk, innoviva is eligible to receive associated royalty revenues from relvar®/breo® ellipta®, anoro® ellipta® and, if approved and commercialized, vi monotherapy, as well. in addition, innoviva retains a 15 percent economic interest in future payments made by gsk for earlier-stage programs partnered with theravance biopharma, inc. for more information, please visit innoviva's website at www.inva.com.

Organization	Innoviva
Employees	112
CEO	Mr. Pavel Raifeld C.F.A.
Industry	Health Technology

Management People of Innoviva

Name	Title
Mr. Pavel Raifeld C.F.A.	Chief Executive Officer
Mr. Stephen Basso M.B.A.	Chief Financial Officer
Ms. Marianne Zhen CPA	Chief Accounting Officer & Secretary
Ms. Patricia M. Drake	Chief Commercial Officer-Innoviva Specialty Therapeutics, Inc.

Important FAQs about investing in Innoviva from India :

What is Innoviva share price today?

Innoviva share price today stands at $17.40, Open: $17.47 ; Previous Close: $17.35 ; High: $17.57 ; Low: $17.29 ; 52 Week High: $21.28 ; 52 Week Low: $14.33. The stock opens at $17.47, after a previous close of $17.35. The stock reached a daily high of $17.57 and a low of $17.29, with a 52-week high of $21.28 and a 52-week low of $14.33.

Can Indians buy Innoviva shares?

Yes, Indians can invest in the Innoviva (INVA) from India.

With INDmoney, you can buy Innoviva at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Innoviva at zero transaction cost.

How can I buy Innoviva shares from India?

It is very easy to buy Innoviva from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Innoviva be purchased?

Yes, you can buy fractional shares of Innoviva with INDmoney app.

What are the documents required to start investing in Innoviva stocks?

To start investing in Innoviva, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.